Literature DB >> 33144453

Clinical Significance of Prognostic Nutritional Index in the Treatment of Esophageal Squamous Cell Carcinoma.

Koji Takao1, Hirotaka Konishi2, Hitoshi Fujiwara1, Atsushi Shiozaki1, Katsutoshi Shoda1, Toshiyuki Kosuga1, Takeshi Kubota1, Tomohiro Arita1, Ryo Morimura1, Yasutoshi Murayama1, Yoshiaki Kuriu1, Hisashi Ikoma1, Masayoshi Nakanishi1, Kazuma Okamoto1, Eigo Otsuji1.   

Abstract

BACKGROUND/AIM: The prognostic nutritional index (PNI) is reported to affect postoperative complications and survival of patients with esophageal squamous cell carcinoma (ESCC). The aim of this study is to investigate the clinical significance of PNI in treatment of ESCC. PATIENTS AND METHODS: Two hundred and sixty-three patients who underwent radical esophagectomy were retrospectively analyzed. PNI was calculated in the pretreatment (pre-Tx), post-neoadjuvant chemotherapy (post-NAC), and postoperative periods.
RESULTS: Pre-Tx PNI positively correlated with prognosis irrespective of undergoing NAC (p<0.05). In the patients with NAC, pre-Tx PNI was one of the independent prognostic factors (p=0.04). In patients with low pre-Tx PNI, the prognosis was improved by increase of PNI after NAC (p=0.08), and two cycles of NAC significantly correlated with high post-NAC PNI (p=0.04).
CONCLUSION: Pre-Tx PNI is an independent prognostic factor irrespective of NAC. Patients in whom the post-NAC PNI can be improved have a high probability of obtaining a good prognosis. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Prognostic nutritional index; esophageal squamous cell carcinoma; esophagectomy; neoadjuvant chemotherapy; prognosis

Mesh:

Year:  2020        PMID: 33144453      PMCID: PMC7811656          DOI: 10.21873/invivo.12184

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  29 in total

1.  Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

2.  Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma.

Authors:  T Nozoe; Y Kimura; M Ishida; H Saeki; D Korenaga; K Sugimachi
Journal:  Eur J Surg Oncol       Date:  2002-06       Impact factor: 4.424

3.  Relationship between immunological parameters and the severity of neutropenia and effect of enteral nutrition on immune status during neoadjuvant chemotherapy on patients with advanced esophageal cancer.

Authors:  Masaaki Motoori; Masahiko Yano; Takushi Yasuda; Hiroshi Miyata; Ying Feng Peng; Makoto Yamasaki; Osamu Shiraishi; Koji Tanaka; Osamu Ishikawa; Hitoshi Shiozaki; Yuichiro Doki
Journal:  Oncology       Date:  2012-07-09       Impact factor: 2.935

4.  Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer.

Authors:  I Schwegler; A von Holzen; J-P Gutzwiller; R Schlumpf; S Mühlebach; Z Stanga
Journal:  Br J Surg       Date:  2010-01       Impact factor: 6.939

5.  Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer.

Authors:  Aude Di Fiore; Stéphane Lecleire; Alice Gangloff; Olivier Rigal; Ahmed Benyoucef; Valérie Blondin; David Sefrioui; Martine Quiesse; Isabelle Iwanicki-Caron; Pierre Michel; Frédéric Di Fiore
Journal:  Dig Liver Dis       Date:  2014-01-14       Impact factor: 4.088

6.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Authors:  Joel Shapiro; J Jan B van Lanschot; Maarten C C M Hulshof; Pieter van Hagen; Mark I van Berge Henegouwen; Bas P L Wijnhoven; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W Ten Kate; Geert-Jan M Creemers; Cornelis J A Punt; John Th M Plukker; Henk M W Verheul; Ernst J Spillenaar Bilgen; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus; Ewout W Steyerberg; Ate van der Gaast
Journal:  Lancet Oncol       Date:  2015-08-05       Impact factor: 41.316

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.

Authors:  Kostan W Reisinger; Joanna W A M Bosmans; Martine Uittenbogaart; Abdulaziz Alsoumali; Martijn Poeze; Meindert N Sosef; Joep P M Derikx
Journal:  Ann Surg Oncol       Date:  2015-04-17       Impact factor: 5.344

9.  Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma.

Authors:  Ji-Feng Feng; Qi-Xun Chen
Journal:  Ther Clin Risk Manag       Date:  2013-12-16       Impact factor: 2.423

Review 10.  Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE).

Authors:  Riccardo Caccialanza; Paolo Pedrazzoli; Emanuele Cereda; Cecilia Gavazzi; Carmine Pinto; Agostino Paccagnella; Giordano Domenico Beretta; Mariateresa Nardi; Alessandro Laviano; Vittorina Zagonel
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

View more
  3 in total

1.  The Modified Glasgow Prognostic Score and Prognostic Nutritional Index as Prognostic Markers in Patients With Metastatic Breast Cancer Treated With Eribulin.

Authors:  Shinya Yamamoto; Shoko Adachi; Tomoko Wada; Kazutaka Narui; Aki Kimura; Masanori Oshi; Akimitsu Yamada; Toshihiro Misumi; Itaru Endo
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.

Authors:  Tianyan Ding; Cantong Liu; Binliang Huang; Lingyu Chu; Laifeng Wei; Yiwei Lin; Yun Luo; Biao Zhang; Chaoqun Hong; Yiwei Xu; Yuhui Peng
Journal:  Cancer Manag Res       Date:  2021-10-09       Impact factor: 3.989

3.  Short- (30-90 days) and mid-term (1-3 years) outcomes and prognostic factors of patients with esophageal cancer undergoing surgical treatments.

Authors:  Meng-Kun Shi; Yun-Qing Mei; Jia-Lun Shi
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.